In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis
- 1 September 2000
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (1) , 61-63
- https://doi.org/10.1016/s0924-8579(00)00198-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant PneumococciAntimicrobial Agents and Chemotherapy, 2000
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumoniaThe Pediatric Infectious Disease Journal, 1995
- In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1994
- Persistent Infection with Chlamydia pneumoniae following Acute Respiratory IllnessClinical Infectious Diseases, 1992
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990